Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective.

导出 LinkOut

翻译打印收藏纠错

作者： Kenneth,LaPensee ^[1] ; Rohit,Mistry ^[2] ; Thomas,Lodise ^[3]

作者单位： Director, Health Economics and Outcomes Research, Paratek Pharmaceuticals, Inc, King of Prussia, PA. ^[1] Senior Associate, Health Economics, PAREXEL Access Consulting, PAREXEL International, London, UK. ^[2] Professor, Albany College of Pharmacy and Health Sciences, NY. ^[3]

关键词 bacterial pneumonia budgetary impact community-acquired bacterial pneumonia economic model omadacycline

PMID 30996766

发布时间 2022-04-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览18

American health & drug benefits

2019年12卷1-Supplement 1期

S1-S12页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective.

American health & drug benefits

相似文献

American health & drug benefits

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective.

American health & drug benefits

相似文献

American health & drug benefits

相关期刊

检索历史清除